drugset / Trial / NCT07342413

Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias

NCT07342413

Phase 4 Not yet recruiting 20 enrolled Goldman, Butterwick, Fitzpatrick and Groff
RandomizedParallel-groupSingle-blindBasic science

Summary

The primary objective is to compare physician-assessed clearance of telangiectatic veins between treatment legs using the Physician Global Aesthetic Improvement Scale (PGAIS). Secondary objectives include assessment of procedural pain, safety outcomes, and patient satisfaction.

Timeline

Start
2026-02-01
Primary completion
2026-05-30
Completion
2026-07-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified
Comparator Glycerin Other / unclassified
Comparator Lidocaine Other / unclassified 1 %

Indications